NASDAQ · Medical - Instruments & Supplies

Azenta, Inc. (AZTA) Stock

$36.00 +0.31% NASDAQ: AZTA Healthcare

Valuation

MetricValue
Price$36.00
Market Cap$1.66B
P/E Ratio-14.09
P/B Ratio1.16
P/S Ratio2.91
EPS (TTM)$0.00
52-Week High$42.73
52-Week Low$15.93
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-7.56%
ROA-6.55%
ROCE-1.33%
Gross Margin-1.85%
Operating Margin-1.85%
Net Margin-20.02%
Debt/Equity0.04
Current Ratio2.97

Annual Financials (USD)

Metric20212022202320242025
Revenue$514.0M$555.0M$665.0M$573.0M$594.0M
Operating Profit$4.0M$-24.0M$-82.0M$-30.0M$-11.0M
Net Profit$111.0M$-429.0M$-14.0M$-165.0M$-56.0M
EPS$1.49$-0.15$-0.22$-3.09$-1.22
Op Margin0.7%-4.3%-12.4%-5.2%-1.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.8B$3.7B$2.9B$2.1B$2.1B
Total Liabilities$494.0M$353.0M$351.0M$331.0M$331.0M
Cash$227.0M$658.0M$679.0M$311.0M$280.0M
Borrowings$95.0M$49.0M$60.0M$71.0M$111.0M

Latest News

Azenta Completes Sale of B Medical Systems PR Newswire · Jul 8, 2026 3 Reasons to Avoid AZTA and 1 Stock to Buy Instead StockStory · Jun 19, 2026 3 Cash-Heavy Stocks We Keep Off Our Radar StockStory · Jun 16, 2026 3 Hyped Up Stocks We Find Risky StockStory · Jun 11, 2026 3 Small-Cap Stocks with Open Questions StockStory · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$150.0M$-466.0M$6.0M$50.0M$72.0M
Investing Cash Flow$-199.0M$1.4B$392.0M$187.0M$-124.0M
Financing Cash Flow$0$-10.0M$-844.0M$-662.0M$-11.0M
Net Cash Flow$-17.0M$756.0M$-357.0M$-363.0M$-24.0M
Free Cash Flow$97.0M$-543.0M$-34.0M$12.0M$38.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.05
EV / EBITDA-17.08
FCF Yield0.55%
Quick Ratio2.21
Interest Coverage0.00
Return 1Y-17.92%
Return 3Y-39.63%
Return 5Y-70.63%

Ownership

Insiders Held1.00%
Institutions Held116.86%
Institutions Float Held118.04%
Institutional HolderSharesReport Date
Blackrock Inc.6,724,9892026-03-31
Politan Capital Management LP4,622,4502026-03-31
Conestoga Capital Advisors, LLC2,844,5462026-03-31
Vanguard Portfolio Management LLC2,450,4922026-03-31
Dimensional Fund Advisors LP2,060,3222026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOBio-Rad Laboratories, Inc. $360.40 -2.04% 44.31 $9.70B 0.00%
BLFSBioLife Solutions, Inc. $38.61 +0.00% 36.07 $1.89B 0.00%
BRKRBruker Corporation $57.92 -3.01% -91.36 $8.82B 0.31%
DHRDanaher Corporation $217.46 -0.47% 39.76 $152.87B 0.71%
HBIOHarvard Bioscience, Inc. $8.13 -4.35% -3.59 $36.67M 0.00%

About Azenta, Inc.

Azenta, Inc. is led by CEO John Marotta, publicly traded since 1995.

Azenta, Inc. (AZTA) stock trades at $36.00 with a market capitalization of $1.66B. The stock is valued at a price-to-earnings (P/E) ratio of -14.09, price-to-book of 1.16, price-to-sales of 2.91. Over the past 52 weeks the stock has ranged between $15.93 and $42.73, and currently trades 15.8% below its 52-week high.

On profitability, Azenta, Inc. generates a return on equity (ROE) of -7.56%, return on capital employed of -1.33%, an operating margin of -1.85%, a net profit margin of -20.02%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides